Yüklüyor......
A Review and Analysis of the YODA Trials: What Can We Glean Clinically?
Medtronic’s biologic, Infuse (rhBMP-2), was approved by the FDA in 2002. Since its approval, a whirlwind of controversy developed culminating in an investigation by the Senate Finance committee. These events led to a landmark agreement between Medtronic and Yale University to perform a comprehensive...
Kaydedildi:
| Yayımlandı: | Curr Rev Musculoskelet Med |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer US
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4596165/ https://ncbi.nlm.nih.gov/pubmed/24903374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12178-014-9220-4 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|